Skip to main content
9,000+ open opportunities indexed

Search Grants — Free, No Account Required

Search federal, state, and foundation grants by keyword, state, or focus area. When you find a match, apply with our AI-assisted application builder.

220 grants foundClear search

24 grants worth up to $187.7M match your search

Enter your email to see grant names, funders, and application links

Developing a Single-Session, Peer-Delivered Internalized Stigma Reduction Intervention for Individuals with Polysubstance Use in Rural Maryland

open

NIDA - National Institute on Drug Abuse

Project Summary/Abstract Rural communities bear a disproportionate burden of opioid and stimulant use, yet many individuals face challenges engaging in and sustaining treatment. Stigmas surrounding substance use disorder (SUD) and medication for opioid use disorder (MOUD) pose substantial obstacles to both engagement in care and achieving optimal treatment outcomes, such as retention and sustained recovery. Internalized stigma, in particular, has been linked to a higher likelihood of overdose. Patients in rural areas describe internalized SUD and MOUD stigmas as significant obstacles to recovery and other treatment outcomes (e.g., retention, continued use, mental health) in recent qualitative work, which are often compounded by stigma related to polysubstance use. Thus, there is a clear need to develop novel solutions for decreasing internalized SUD and MOUD stigmas within under-resourced, rural communities. Peer recovery specialists (PRSs), or individuals with lived experience in SUD and recovery, may be a unique solution to shifting stigma through sharing their lived experience and normalizing the experience of living with or in recovery from a SUD. While research supports PRS-delivery of brief evidence-based interventions, recent evidence also suggests that PRS-contact through non-stigma focused interventions may not be sufficient in sustaining long-term decreases in internalized stigma. Interventions to target internalized SUD and related stigmas, such as acceptance and commitment therapy (ACT), have shown promise in decreasing internalized stigma and its associated consequences (e.g., avoidance, shame), even when delivered in brief formats. However, these interventions are often limited to high-resource settings. Given the vast resource constraints in rural contexts, a brief PRS-delivered intervention for stigma reduction may be particularly feasible in increasing access to evidence-based care and reducing internalized SUD and MOUD stigmas. Thus, this study aims to: (1) evaluate patient-perceived appropriateness and potential obstacles and facilitators in the implementation of the proposed intervention in an under-resourced, rural context using a qualitative approach with MOUD patients and staff (N = 30); (2) iteratively adapt the proposed intervention and implementation strategies with three structured co-creation sessions (N = 12), guided by ADAPT-ITT and human- centered design principles; and (3) guided by ADAPT-ITT’s theater testing approach, evaluate the feasibility and acceptability of the adapted intervention components using mixed methods (N = 15).

Up to $107K
2028-04-30
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

DYNAMO?Diabetes in Youth and Young Adults of the Pacific Northwest

open

NCCDPHP - National Center for Chronic Disease Prev and Health Promo

Project summary Type 1 and type 2 diabetes mellitus (T1D, T2D) continue to rise in youth and young adults (YYA) worldwide, with disproportionately high rates of T2D among historically underserved populations. Young people with early-onset diabetes face decades of managing a complex chronic disease and are at heightened risk of complications. Despite advancements, key knowledge gaps persist regarding trends in early onset T1D and T2D incidence, disease management, and outcomes in real-world settings, particularly for young adults, rural communities, and those receiving care outside specialty centers. The transition to adulthood, which often involves changes in residence, employment, and insurance, complicates surveillance through traditional methods. To address these challenges, we have brought together a highly collaborative, multi-institutional team of endocrinologists, biostatisticians, epidemiologists, nephrologists and informaticists with experience in diabetes surveillance and electronic health record-based research. We have established a unique regional network of five major health systems across the Pacific Northwest (PNW) to conduct comprehensive diabetes surveillance in YYA. This network includes Seattle Children’s Hospital, University of Washington Medicine, Providence Health System, Virginia Mason Franciscan Health, and the Veterans Affairs VISN 20 region, collectively serving diverse urban and rural populations across Washington, Oregon, Idaho, Montana, and Alaska. By integrating EHR, claims data, and established research infrastructure, we will conduct systematic surveillance of diabetes incidence, prevalence, clinical management, and complications in YYA. Our central hypothesis is that tracking diverse demographics, including rural and Native populations, will uncover critical disparities in the diabetes burden, healthcare delivery, and outcomes amenable to targeted interventions. Data will be harmonized across the health systems in our network. We will contribute to and implement the shared protocol developed with other funded sites in this cooperative grant mechanism. This project will deliver the first large-scale, real-world surveillance system for YYA with diabetes in the PNW, capturing underrepresented populations and addressing a pressing need for timely data on evolving trends in care and outcomes. By systematically identifying disparities in disease burden and clinical management, results will inform interventions to prevent disease progression, reduce complications, and improve long-term quality of life. The focus on rural and Native populations ensures that our approach is inclusive, contextually relevant, and poised to directly influence public health efforts in regions often overlooked by surveillance studies.

Up to $500K
2029-09-29
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Enhancing PCP-Nephrologist Co-Management for CKD: Leveraging Population Health Management and Learning Health System for Scalable Solutions

open

NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases

Abstract Chronic kidney disease (CKD) afflicts 37 million Americans and leads to increased morbidity, mortality, and healthcare costs. With emerging CKD guidelines and highly effective new therapeutics, there is an urgent call for scalable and resource-efficient population-level approaches to optimize CKD care. The overarching goal of this proposal is to evaluate clinical- and cost-effectiveness of a multifaceted population health management (PHM) implementation approach that facilitates PCP and nephrology co-management to deliver evidence-based CKD care. Using a learning health system approach, we developed and implemented Kidney-Care, which is a novel, electronic-health record (EHR) based, multi-faceted PHM intervention. It builds on successful elements of our prior Kidney- Coordinated HeAlth Management Partnership (K-CHAMP) program, which included centralized, remotely delivered intervention bundle with timely nephrology E-consults, pharmacist-led medication management, nurse-led standardized patient education, and PCP academic detailing. In the enhanced K-Care program, we targeted PCP’s therapeutic inertia and unfamiliarity with new guidelines through reinforced academic detailing and experiential case-based learning through E-consults. We targeted patient behavior change through education on CKD prioritization and importance of newer medications, hired a renal social worker to address medication affordability and social risk factors, and expanded our team with a renal dietitian and renal-palliative clinicians. K-Care program scaled up the intervention to 101 PCP practices within our health system, providing access to ~ 24% rural-living patients. The proposed study provides a unique timely opportunity to answer the following specific aims: 1) To compare the long-term clinical effectiveness of a multifaceted CKD PHM intervention versus usual care on renal and cardiovascular (CV) outcomes among patients with CKD at moderate-high risk of ESKD; 2) To evaluate effectiveness of CKD PHM intervention in improving guideline-concordant care compared to usual care; 3) To assess the cost-effectiveness of CKD PHM intervention compared to usual care. Using EHR data, we will conduct a target trial emulation to determine the 5-year intent-to-treat effect of the K-Care program (n~3000) compared to contemporary usual care using inverse probability of treatment weighted marginal structural models. Our primary composite outcome is CKD progression (≥ 40% decline in eGFR or ESKD) or CV death. Secondary outcomes include hospitalization for heart failure or CV death, hospitalization for any cause, death from any cause, CKD progression, CV death, and major adverse CV events. We will also evaluate guideline-concordant care outcomes (hypertension and glycemic control, albuminuria testing, medication use) and incremental cost effectiveness ratio per quality-adjusted life-year gained. This proposal aligns with value-based CKD goals outlined by Center for Medicare & Medicaid Services and the Advancing American Kidney Health Initiative.

Up to $753K
2030-03-31
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Epigenetic and genetic regulation of arsenic methylation and arsenic-relatedcardiovascular disease risk

open

NIEHS - National Institute of Environmental Health Sciences

SUMMARY In the United States, Native American communities face the greatest burden of chronic diseases among all ethnic groups and high rates of cardiovascular disease (CVD) incidence and mortality. Elevated disease risk may be in part attributed to arsenic in drinking water, which is a key environmental risk factor among rural households that rely on private wells. Arsenic-related CVD risk may be modified by the biomethylation of arsenic, a pathway that decreases arsenic toxicity and increases urinary excretion. Arsenic methylation efficiency varies between individuals and populations and is influenced by genetic variation. However, the role of pre- and post- transcriptional gene regulatory factors, including DNA methylation (DNAm) and microRNAs, on arsenic methylation efficiency and arsenic-induced CVD is not fully understood. This study will leverage data and biospecimens representing multiple omics layers from the Strong Heart Study (SHS) and Strong Heart Family Study (SHFS), large, prospective, well characterized cohorts of Native American adults with longitudinal data on CVD outcomes and risk biomarkers. The aims of this project are to (K00, Aim 1) determine the relationship between DNAm, arsenic methylation efficiency, and CVD to identify epigenetic biomarkers of arsenic toxicity and arsenic-related disease risk; (K99, Aim 2) determine the effect of genetic variation on DNAm associated with arsenic methylation efficiency to distinguish molecular mechanisms underlying arsenic methylation phenotypes; and (R00, Aim 3) investigate the role of microRNAs in mediating the association between arsenic exposure and methylation efficiency and CVD risk biomarkers to elucidate molecular processes underlying arsenic-related CVD. To accomplish these aims, Dr. Bozack will be receive mentorship from experts in environmental, molecular, and genetic epidemiology. In the K99 phase, Dr. Bozack will also receive training in bioinformatics and machine learning, including approaches for developing DNAm biomarkers and investigating gene-epigene interactions. In the R00 phase, she will generate circulating microRNA expression data and will further apply her training in clustering and network analyses to identify microRNA signatures linking arsenic exposure and methylation efficiency to CVD risk. The proposed training and research will enable Dr. Bozack to establish an independent research path focusing on biomarker development and applying multiple omics approaches to environmental molecular epidemiology. Furthermore, mentorship and career development activities will facilitate her transition to an independent researcher. Overall, this study will advance the understanding of gene regulatory factors involved in arsenic-related CVD risk through a multiple omics perspective, which is necessary to unravel the relationship between environmental and biological factors involved in the etiology of complex diseases. Findings will contribute the development of noninvasive biomarkers of arsenic-related CVD risk and may aid in targeting arsenic mitigation and public health interventions.

Up to $249K
2029-05-31
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Establishing the University of Arizona Cancer Center as a Lead Academic Participating Site in the National Clinical Trials Network

open

NCI - National Cancer Institute

Project Summary The overall goal of this application is to establish the University of Arizona Cancer Center (UACC) as a Network Lead Academic Participating Site (LAPS) for the NCI’s National Clinical Trials Network (NCTN). As the only NCI-Designated Comprehensive Cancer Center headquartered in the state of Arizona, the UACC currently provides significant leadership and mentorship in the development and conduct of important translational and therapeutic clinical trials for cancer patients across the state. This application will enhance participation and bolster the UACC’s infrastructure capabilities to continue to provide scientific leadership in the development and conduct of clinical trials and substantial accrual to clinical trials across the state and entire NCTN while simultaneously training the next generation of clinical investigators in state-of-the art clinical trials for the treatment of adult cancer patients. Specifically, this will support the UACC’s infrastructure to increase clinical research activities, protocol development, investigator leadership and junior faculty mentorship. UACC has a strong track record of past and present leadership and participation in the NCTN Program and will continue this participation as a LAPS site. We will achieve our goal through the following Aims: 1) to develop, lead, and participate in scientifically and clinically relevant NCTN clinical trials; 2) to support robust accrual, timely and accurate data reporting and internal monitoring for NCTN trials; 3) to support accrual at satellites sites across the state of Arizona as part of the Arizona Clinical Trials Network; and 4) to serve the community by utilizing a Clinical Trials Oncology Navigation program to assist with trial education and enrollment and retention of patients reflective of our catchment populations and the state of Arizona. We plan to do this through creating a LAPS Leadership Committee for oversight and mentoring, by working with the Clinical Trials Navigator to educate patients on clinical trials, and specifically targeting sites with access to rural and other underserved populations.

Up to $310K
2032-05-31
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Examining a Digital Perinatal Smoking-Cessation Intervention

open

NIDA - National Institute on Drug Abuse

PROJECT SUMMARY Cigarette smoking is the leading preventable cause of poor pregnancy outcomes in the U.S., contributing to serious adverse events ranging from catastrophic pregnancy outcomes to later-in-life metabolic syndrome. Perinatal smoking has a disproportionate adverse impact on populations with constrained access to healthcare (e.g., rural residents). We developed a clinic-based financial-incentives (FI) intervention for perinatal smoking cessation that has been shown to be efficacious and cost-effective in randomized controlled trials (RCTs) and meta-analyses. Indeed, in 2024 the United Kingdom announced national implementation of clinic-based FI for perinatal smoking delivered by National Health Service tobacco interventionists. Unfortunately, scaling clinic- based versions in the U.S. is difficult as many prenatal-care clinics and hospitals fail to provide smoking- cessation services, especially in rural regions where many obstetrical services or entire hospitals are closing. Hence, we developed a digital FI intervention in collaboration with DynamiCare Health Inc. In a Phase 2 RCT that we conducted with 90 pregnant participants recruited across 33 U.S. states, adding this digital FI intervention to best practices (BP+FI) increased odds of cessation 4-fold above BP alone. Maximum FI earnings possible in that trial were $1,620 across the approximately 9-month intervention, with a mean [SD] incentive payout of $331 [446] per women treated. This smartphone-based digital FI intervention previously received Food and Drug Administration (FDA) Breakthrough Device Designation. We are submitting this UG3/UH3 application to conduct Phase 2 (UG3) and Phase 3 (UH3) RCTs in collaboration with FDA with the overarching aim of having this digital FI intervention authorized as an FDA Approved Digital Therapeutic. The UG3 Phase 2 RCT will address a January 2025 Substance Abuse and Mental Health Services Administration advisory that caps maximum potential earnings in FI for treating substance use disorders at $750 when using federal funds. Because federal funds will be essential to successful U.S. implementation of this digital FI intervention, we propose to conduct a UG3 Phase 2 RCT (N=137) examining the efficacy of BP+FI with $750 maximum earnings versus BP alone. Based on prior FI RCTs and meta-analyses, we hypothesize that BP+FI will remain efficacious with a $750 maximum although with a smaller effect size than at the $1,620 value which is why we are proposing a larger sample size in the UG3 than our prior Phase 2 RCT. Go/no-go criteria for the UG3 phase are: (1) complete an FDA Q-submission and (2) the UG3 trial results support the efficacy of BP+FI at $750 maximum earnings for increasing antepartum smoking abstinence significantly above BP alone. If these benchmarks are met , we propose to conduct a UH3 effectiveness trial (N to be informed by UG3 results and FDA recommendations) examining overall smoking abstinence, birth outcomes, treatment acceptability, and cost-effectiveness. Overall, this digital FI intervention has potential to bring sorely needed and effective perinatal smoking-cessation services to U.S. women including rural residents and others with constrained access to healthcare.

Up to $732K
2028-04-30
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Exploring the Implementation of Medicaid Alternative Payment Models and Evidence Based Practices in Federally Qualified Health Centers to Improve Diabetes Health Outcomes

open

NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases

Project Summary Diabetes mellitus (DM) is a leading cause of morbidity in the United States, costing over $400 billion annually and disproportionately affecting individuals in rural and low-income communities. Federally Qualified Health Centers (FQHCs) serve over 30 million patients each year, including 10% of all individuals with DM in the US, and primarily operate in Health Professional Shortage Areas as a critical source of care for many rural and lower income communities. However, traditional Medicaid payment models have often constrained FQHCs’ ability to deliver high-quality, coordinated chronic disease care. In response, 40 state Medicaid programs have introduced Alternative Payment Models (APMs) to incentivize FQHCs to 1) improve patient health outcomes and 2) lower costs. While evidence suggests APMs may improve DM outcomes, the mechanisms by which FQHCs implement these models—and whether rural and urban clinics adapt differently—remain unknown. This K01 proposal directly supports NIDDK’s strategic goals in Dissemination and Implementation Research and Stakeholder Engagement by partnering with FQHCs to study real-time implementation of APMs and evidence-based practices (EBPs) in DM care. The project has three aims: (1) to identify APM and FQHC features that influence implementation and characterize EBP adoption through qualitative interviews; (2) to assess the association between APM/FQHC characteristics and implementation success via a national survey; and (3) to evaluate the impact of APM types on HBA1c control rates using Uniform Data System (UDS) data and a difference-in-differences design. Guided by the Consolidated Framework for Implementation Research (CFIR) and Proctor’s Implementation Outcomes Framework, this study will generate actionable insights for policymakers and FQHC leaders. It is innovative in its integration of policy analysis, implementation science, and health economics, and in its real-time collaboration with FQHCs undergoing APM transitions. The candidate Dr. Justin Markowski, an applied health economist with prior FQHC experience and a strong publication record on rural health policy and FQHCs, will receive mentored training in implementation science, qualitative methods, survey design, and chronic disease research. This training will prepare him to develop an R01 proposal to develop and test implementation strategies to overcome the challenges identified in this K01 proposal and help FQHCs improve diabetes health outcomes. In doing so, this work seeks to inform the design of future Medicaid APMs and support NIDDK’s mission to improve the health of rural and low-income patients with diabetes through healthcare innovation and the implementation of evidence-based practices in FQHCs.

Up to $161K
2029-03-31
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Facilitating Ultrasound Utilization for Diagnosis of Abdominal Pain in Rural Children

open

NIMHD - National Institute on Minority Health and Health Disparities

Project Summary/Abstract Rural populations have decreased access to diagnostic ultrasound, which provides a low-cost and radiation­free method for evaluating abdominal pain in children. As a result, many children are evaluated with computed tomography, which increases imaging costs, radiation exposure, and cancer risks. This lack of access to appropriate imaging exacerbates the existing widespread disparities in health outcomes among the 13 million children who live in rural areas. This disparity in imaging practices has been noted nationally for over a decade without successful implementation of a solution. The long-term objective of this research is to increase access to ultrasound for diagnostic imaging for underserved children in rural areas, thereby increasing the quality, safety, and value of care. This research will provide insights for a national approach to increase ultrasound utilization and then focus specifically on Appalachia, an economically distressed region where the urban-rural divide in healthcare access is particularly striking. The aims of the research will be guided by the Practical Implementation Sustainability Model (PRISM)/Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) implementation framework, adapted to the specific overarching goal of this research. Aim 1 will simulate the reach and effectiveness of three ultrasound utilization models to increase ultrasound utilization and decrease radiation exposure for children evaluated with abdominal pain. Aim 2 will identify patient, facility, and area-level contextual factors that are associated with variable ultrasound use among low­income children in rural Appalachian communities. Aim 3 will use qualitative methods to identify caregiver and organizational-level contextual factors that influence ultrasound utilization for rural children at community hospitals in Appalachia. These aims will define the underlying causes of imaging disparities in rural children, guide selection of the best approach to improve access to guideline-adherent imaging, and develop a feasible and acceptable implementation strategy to increase ultrasound utilization for rural children. This study will also develop children's hospital/community hospital partnerships through which an evidence-based implementation approach to reduce imaging-related disparities in rural areas can be tested in future work.

Up to $446K
2028-06-30
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

Fertilizer Investment & Expansion for Long-term Domestic Supply (FIELDS)

open

Rural Business-Cooperative Service

Fertilizer Investment & Expansion for Long-term Domestic Supply (FIELDS) Program The Fertilizer Investment & Expansion for Long-term Domestic Supply (FIELDS) Program is intended to expand or bring into operation new, independent domestic fertilizer production capacity in order to provide agricultural producers with additional domestic fertilizer options and strengthen the U.S. fertilizer supply chain. Program funding is intended to support projects that significantly increase domestic fertilizer manufacturing capacity and availability. Eligible projects may include expansions or upgrades of existing facilities, construction of new domestic production facilities, shovel-ready projects capable of rapidly increasing domestic supply, and on-site fertilizer terminals and transportation infrastructure that improve supply chain efficiency. Notice of Funding Opportunity Update 7/7/2026 The following updates have been made to the Fertilizer Investment & Expansion for Long-term Domestic Supply (FIELDS) Notice of Funding Opportunity: Maximum competitive award cap increased: Revised from competitive, cost-share awards of up to $100 million to competitive, cost-share awards of up to $150 million. Approximate number of awards clarified: The Notice of Funding Opportunity now states that approximately 10 awards are anticipated. Restriction on pre-development costs added: The updated version explicitly states that pre-development costs cannot be the primary use of funds, consistent with the existing limitation on working capital. Section 3.3, Other Eligibility Requirements: Removed the following language: Ensuring compliance with packaging and labeling requirements under applicable law (including sealing, packaging, boxing, labeling, conveying, and product moving equipment).

$15M – $150M
2026-08-17
business developmentcommerce

Free to search & build · $99 one-time to unlock the application pack · No subscription

FY26 Law Enforcement Mental Health and Wellness Act Program

open

Community Oriented Policing Services

The Office of Community Oriented Policing Services (COPS) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing and the Administration’s priority of Making America Safe Again by supporting the nation’s state, local, territorial and Tribal law enforcement agencies through information and grant resources. This is a notice of funding opportunity (NOFO) for the FY26 Law Enforcement Mental Health and Wellness Act (LEMHWA) Program. The mental health and wellness of law enforcement officers and their families is a priority of the Administration. Through the LEMHWA program, the Department of Justice supports this priority by providing funding directly to state, local, tribal, and territorial (SLTT) law enforcement agencies to implement new or enhance existing programs that offer training and services to support officers emotional and mental health including, counseling programs, peer mentoring, suicide prevention, stress reduction, and police officer family services. As community policing is common sense policing, throughout the FY26 LEMHWA program NOFO materials, the terms “community policing” and “common sense policing” are used interchangeably, unless otherwise specified. The COPS Office seeks to increase the delivery of and access to mental health and wellness services through this NOFO in the following three funding categories: Category 1: FY26 Start-up LEMHWA Implementation Projects • The purpose of this program is to provide funding to law enforcement agencies that do not have established law-enforcement specific mental health and wellness programming. These funds will serve as start-up funding to support the development of new mental health and wellness services and programming for employees of law enforcement agencies and their families. This program also serves to increase grant funding accessibility for small and understaffed departments, especially those in rural communities, to implement mental health and wellness programs. • Implementation of peer support, training, family resources, suicide prevention, stress reduction, clinical support, and other promising practices for wellness programs are highly encouraged. • Agencies that currently offer rudimentary or limited wellness services and are seeking to develop a comprehensive wellness program for their department are encouraged to apply. Category 2: FY26 Enhanced LEMHWA Implementation Projects • The purpose of this program is to provide funding to law enforcement agencies who have current wellness programs in place and are seeking to enhance or expand upon those existing wellness programs. Category 3: FY26 LEMHWA Community of Practice Initiative The purpose of this initiative is to provide support to current and future LEMHWA grantees, that include peer support and technical assistance through the development and facilitation of an innovative forum where grantees can learn from their peers and share promising practices.

Up to $250K
2026-07-30
law_justice_and_legal_services

Free to search & build · $99 one-time to unlock the application pack · No subscription

FY26 Law Enforcement Mental Health and Wellness Act Program

open

Community Oriented Policing Services

The Office of Community Oriented Policing Services (COPS) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing and the Administration s priority of Making America Safe Again by supporting the nation s state, local, territorial and Tribal law enforcement agencies through information and grant resources. This is a notice of funding opportunity (NOFO) for the FY26 Law Enforcement Mental Health and Wellness Act (LEMHWA) Program. The mental health and wellness of law enforcement officers and their families is a priority of the Administration. Through the LEMHWA program, the Department of Justice supports this priority by providing funding directly to state, local, tribal, and territorial (SLTT) law enforcement agencies to implement new or enhance existing programs that offer training and services to support officers emotional and mental health including, counseling programs, peer mentoring, suicide prevention, stress reduction, and police officer family services. As community policing is common sense policing, throughout the FY26 LEMHWA program NOFO materials, the terms community policing and common sense policing are used interchangeably, unless otherwise specified. The COPS Office seeks to increase the delivery of and access to mental health and wellness services through this NOFO in the following three funding categories: Category 1: FY26 Start-up LEMHWA Implementation Projects The purpose of this program is to provide funding to law enforcement agencies that do not have established law-enforcement specific mental health and wellness programming. These funds will serve as start-up funding to support the development of new mental health and wellness services and programming for employees of law enforcement agencies and their families. This program also serves to increase grant funding accessibility for small and understaffed departments, especially those in rural communities, to implement mental health and wellness programs. Implementation of peer support, training, family resources, suicide prevention, stress reduction, clinical support, and other promising practices for wellness programs are highly encouraged. Agencies that currently offer rudimentary or limited wellness services and are seeking to develop a comprehensive wellness program for their department are encouraged to apply. Category 2: FY26 Enhanced LEMHWA Implementation Projects The purpose of this program is to provide funding to law enforcement agencies who have current wellness programs in place and are seeking to enhance or expand upon those existing wellness programs. Category 3: FY26 LEMHWA Community of Practice Initiative The purpose of this initiative is to provide support to current and future LEMHWA grantees, that include peer support and technical assistance through the development and facilitation of an innovative forum where grantees can learn from their peers and share promising practices.

Up to $250K
2026-07-30
lawjustice

Free to search & build · $99 one-time to unlock the application pack · No subscription

FY26 Pathways to Removing Obstacles to Housing (PRO Housing)

open

Department of Housing and Urban Development

As President Trump said in his Executive Order on Removing Regulatory Barriers to Affordable Home Construction (March 13, 2026), The American dream of homeownership depends on a dynamic housing market in which a varied inventory of new homes is built and renovated each year. Layers of unnecessary regulatory barriers, slow permitting processes, and onerous mandates at all levels of government have delayed construction, restricted development, and driven up the costs of new housing. These constraints have made housing less affordable for many Americans.It is the policy of my Administration to reduce regulatory barriers to building homes and to steward taxpayer dollars in a manner that promotes housing affordability.HUD's PRO Housing program rewards communities that have taken steps to remove regulatory barriers to building and preserving homes by providing funding to further expand affordable housing, particularly homeownership opportunities and housing located in Opportunity Zones and rural communities.HUD is issuing this Fiscal Year 2026 (FY26) PRO Housing NOFO under the authority of the Consolidated Appropriations Act, 2026, which provided $50 million for competitive grant funding for state and local governments, metropolitan planning organizations (MPOs), and multijurisdictional entities. The Appropriations Act requires HUD to award grants using the Community Development Block Grant (CDBG) framework. As with all CDBG assistance, the priority is to serve low- and moderate-income people and households. HUD shall select applicants that demonstrate: (1) progress and a commitment to eliminating local barriers to facilitate the increase in affordable housing production and preservation, through enactment or implementation of less restrictive zoning, land use, or permitting laws and regulations; (2) an acute need for housing affordable to households with incomes below 100 percent of the area median income; and (3) a commitment to create new homeownership units before the expiration of the funding performance period.Applicants and grantees are reminded of the President's Executive Orders on Ending Illegal Discrimination and Restoring Merit-Based Opportunity (January 221, 2025) and Ending Radical and Wasteful Government DEI Programs and Preferences (January 20, 2025) and their applicability to PRO Housing funding. PRO Housing funding may not be used to fund "illegal and immoral discrimination programs, going by the name 'diversity, equity, and inclusion.'"In addition to thoroughly reviewing this NOFO, applicants are strongly encouraged to monitor HUD's PRO Housing website for information about general updates, Frequently Asked Questions, and PRO Housing webinars.HUD has four goals for this competition:Decrease the cost and increase the supply of affordable housing, especially in Opportunity Zones and rural communities.Remove barriers to affordable housing, removal of which will lead to constructing or rehabilitating more units, reducing time to produce units, and unlocking land that can be used for affordable housing units.Reward jurisdictions that have enacted laws and regulations that will lead to more affordable housing production and preservation.Increase opportunities for affordable homeownership by reducing administrative and structural barriers.

$5M – $10M
2026-08-03
community development

Free to search & build · $99 one-time to unlock the application pack · No subscription

FY26 Pathways to Removing Obstacles to Housing (PRO Housing)

open

Department of Housing and Urban Development

As President Trump said in his Executive Order on Removing Regulatory Barriers to Affordable Home Construction (March 13, 2026), The American dream of homeownership depends on a dynamic housing market in which a varied inventory of new homes is built and renovated each year. Layers of unnecessary regulatory barriers, slow permitting processes, and onerous mandates at all levels of government have delayed construction, restricted development, and driven up the costs of new housing. These constraints have made housing less affordable for many Americans.It is the policy of my Administration to reduce regulatory barriers to building homes and to steward taxpayer dollars in a manner that promotes housing affordability.HUD's PRO Housing program rewards communities that have taken steps to remove regulatory barriers to building and preserving homes by providing funding to further expand affordable housing, particularly homeownership opportunities and housing located in Opportunity Zones and rural communities.HUD is issuing this Fiscal Year 2026 (FY26) PRO Housing NOFO under the authority of the Consolidated Appropriations Act, 2026, which provided $50 million for competitive grant funding for state and local governments, metropolitan planning organizations (MPOs), and multijurisdictional entities. The Appropriations Act requires HUD to award grants using the Community Development Block Grant (CDBG) framework. As with all CDBG assistance, the priority is to serve low- and moderate-income people and households. HUD shall select applicants that demonstrate: (1) progress and a commitment to eliminating local barriers to facilitate the increase in affordable housing production and preservation, through enactment or implementation of less restrictive zoning, land use, or permitting laws and regulations; (2) an acute need for housing affordable to households with incomes below 100 percent of the area median income; and (3) a commitment to create new homeownership units before the expiration of the funding performance period.Applicants and grantees are reminded of the President's Executive Orders on Ending Illegal Discrimination and Restoring Merit-Based Opportunity (January 221, 2025) and Ending Radical and Wasteful Government DEI Programs and Preferences (January 20, 2025) and their applicability to PRO Housing funding. PRO Housing funding may not be used to fund "illegal and immoral discrimination programs, going by the name 'diversity, equity, and inclusion.'"In addition to thoroughly reviewing this NOFO, applicants are strongly encouraged to monitor HUD's PRO Housing website for information about general updates, Frequently Asked Questions, and PRO Housing webinars.HUD has four goals for this competition:Decrease the cost and increase the supply of affordable housing, especially in Opportunity Zones and rural communities.Remove barriers to affordable housing, removal of which will lead to constructing or rehabilitating more units, reducing time to produce units, and unlocking land that can be used for affordable housing units.Reward jurisdictions that have enacted laws and regulations that will lead to more affordable housing production and preservation.Increase opportunities for affordable homeownership by reducing administrative and structural barriers.

$5M – $10M
2026-08-03
Community DevelopmentHousingopportunity_zone_benefits

Free to search & build · $99 one-time to unlock the application pack · No subscription

G-RISE at Northern Arizona University

open

NIGMS - National Institute of General Medical Sciences

Project Summary The primary mission of the G-RISE program at Northern Arizona University (NAU) is to strengthen the PhD trained biomedical and health focused scientist workforce by enhancing institutional capacity and promoting broader participation in rigorous research training. NAU is ideally positioned to contribute to this mission because of the high number of students from disadvantaged backgrounds, combined with strong existing feeder programs, an institutional commitment to educational excellence and upwards mobility and strong and rapidly growing biomedical research productivity. The overarching goal of G-RISE at NAU is to enhance the recruitment, participation and retention of PhD students across 4 PhD programs in Biology, Earth Sciences and Environmental Sustainability, Informatics and Computing, and Interdisciplinary Health. We aim to use an innovative wrap-around mentorship support system shown to be effective at our institution for students from a range of backgrounds including students from rural areas, first-generation college students, indigenous and Hispanic students. Our activities build on a range of successful training programs primarily at the undergraduate and masters’ levels, including a RISE R25 and research education and investigator development cores of NIH-funded collaborative partnership grants. Specifically, to accomplish our goal, we will provide 1) foundational research training including curricular programming, training in NIH rigor and reproducibility and Responsible Conduct of Research; 2) hands-on research experiences including applied research training during the academic year, summer enrichment experiences and exposure to role models from indigenous and other underrepresented backgrounds; and 3) career development training, including development of a mentorship team, grant writing training, peer-reviewed manuscript writing, training in oral communication skills and support in applying to external workshops and professional positions. We aim to support 8 students each year and support them for 2 years each, for up to 20 students for the proposed 5-year cycle. Our program is further boosted by a strong institutional commitment, further enhancing chances of success. The measurable outcomes are to retain at least 80% of students, and at least 65% of trainees will graduate within 6 years of starting their respective PhD program. In addition, at least 80% of students will present research results at a scientific conference and co-author a scientific manuscript, with the goal of at least one product per year starting in their second year. Finally, at least 75% of graduates will work in a field related to biomedical science or translational health research. We believe G-RISE at NAU will provide the necessary and timely support and research training needed to increase capacity of our trainees to conduct research relevant to their communities, lower the years to degree attainment and strengthen the PhD trained biomedical workforce.

Up to $218K
2031-06-30
health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

FindGrants Pro

Save unlimited matches with FindGrants Pro — $19/mo

Includes 1 application credit per month, weekly emailed grant alerts matching your org, and deadline reminders. Cancel anytime.

See Pro details

Found a grant that fits? Get matched to even more.

Answer a 2-minute questionnaire and our engine scores every grant in the database against your organization — surfacing opportunities you might miss browsing manually.

Get Personalized Matches — Free